baber/WOPTO huggingface dataset:
Patent AU-643370-B2 (AU)
Title: System for monitoring signal quality in an optical network
Inventor: HEIDEMANN ROLF DR
IPC: H04B10/00
Filed: 1992-03-09
Granted: 1993-11-11
Abstract: Operators of fibre-optical transmission networks would like to monitor the signal quality at certain points in the network (for example at the network termination points). The invention specifies a system for this in which 
 
  - the useful signal (S1) is monitored indirectly, i.e. by monitoring an auxiliary signal (S2); 
  - the means (4, 5, 6, 7) necessary for this can be simultaneously used for setting up a service channel between network node (1) and monitoring point (4); 
  - the means necessary for this can be supplemented with little expenditure so that the signal monitoring can be coupled with an (advantageous) signal amplification. 
 
<IMAGE>
Patent AU-601270-B2 (AU)
Title: Process for separation of rare earths
Inventor: DELLOYE THIERRY
IPC: C22B3/00
Filed: 1988-03-22
Granted: 1990-09-06
Abstract: Rare-earth elements present in aqueous solutions are separated using a solvent by a process which consists in performing a liquid- liquid extraction between an aqueous phase containing the rare-earth nitrates and an organic phase, characterised in that a mixture of organophosphorus compounds is used as extraction agent. <IMAGE>
Patent AU-597210-B2 (AU)
Title: Reducing the concentration of pollutanta in an effluent
Inventor: EPPERLY WILLIAM ROBERT
IPC: B01J8/00
Filed: 1988-03-04
Granted: 1990-05-24
Abstract: A process is presented for reducing the concentration of pollutants in an effluent from the combustion of a carbonaceous fuel. The process comprises injecting a first treatment agent into the effluent at a first temperature zone and injecting a second treatment agent into the effluent at a second temperature zone, wherein the first and second treatment agents are injected under conditions effective to reduce the effluent pollution index.
Patent AU-606170-B2 (AU)
Title: Process for the production of 2,3,5,6-tetrachloropyridine and 2,3,6-trichloropyridine
Inventor: DESJARDIN MICHAEL A
IPC: C07D213/61
Filed: 1988-05-12
Granted: 1991-01-31
Abstract: Vapor phase chlorination of 2,6-dichloropyridine produces 2,3,6-trichloropyridine selectively over isomeric 2,4,6-trichloropyridine and of 2,3,6-trichloropyridine produces 2,3,5,6-tetrachloropyridine in high selectivity over isomeric 2,3,4,6-tetrachloroyridine at temperatures of 300 DEG C to 450 DEG C. The products are intermediates for insecticides and herbicides.
Patent AU-768147-B2 (AU)
Title: Granules for oral administration, process for producing the same, and tablets produced from the granules
Inventor: KITAMURA SHUJI
IPC: A61K31/00
Filed: 2000-01-11
Granted: 2003-12-04
Abstract: Granules and tablets for oral administration, containing angiotensin-converting enzyme inhibiting peptides and treated whey with a mixing fluid bed processor, wherein said whey is obtained from lactic acid fermentation liquid. The granules have properties of narrow particle distributions, low moisture absorption, and heavy specific gravity, as well as high free flowing. A process is also provided for producing the granules by the steps of:a) onto seed granules obtained in an earlier operation in a mixing fluid bed processor, spraying purified whey of lactic acid fermentation liquid to form preliminary granules;b) treating the preliminary granules thus obtained to reduce particle size in a size reduction mill;c) returning the treated powder to the mixing fluid bed processor, and,d) spraying additional purified whey onto the returned powder in the mixing fluid bed processor to form granules, while fluidizing the said powder.
Patent AU-762151-B2 (AU)
Title: ACD tier based routing
Inventor: HYMEL DARRYL
IPC: H04M3/523
Filed: 2000-02-28
Granted: 2003-06-19
Abstract: A method is provided for assigning agents of a plurality of agent groups to a agent pool for answering a call based upon a time delay for answering the call. The method includes the steps of designating a first agent group as candidates for answering a call based upon first availability, forming an expanded group of the first group and at least some agents of a second group when the time delay exceeds a threshold and assigning the call to an agent of the expanded group based upon first availability. <IMAGE>
Patent AU-692243-B2 (AU)
Title: Method to control the deformations of the sidewalls of a crystalliser, and continuous-casting crystalliser
Inventor: BENEDETTI GAIMPIETRO
IPC: B22D11/22
Filed: 1995-05-24
Granted: 1998-06-04
Abstract: Method to control the deformations of the sidewalls of a crystalliser (11) for the continuous casting of billets/blooms /slabs (24), which is associated with a mould (10) and cooperates externally with a box-shaped structure (13) creating a cooling chamber (14), in which a cooling fluid circulates, and cooperates internally with the skin of the billets/blooms /slabs (24) being formed, the cooling chamber (14) containing an intermediate wall (20) creating a circulation channel (21) in cooperation with the outer surface of the sidewall (12) of the crystalliser (11), at least one upper zone (37) being included in cooperation at least with the vicinity of the meniscus and with the portion below the meniscus (27) of liquid metal, a lower zone (38) being also included and beginning in the vicinity of the zone of separation of the forming skin from the inner surface of the sidewall (12) of the crystalliser (11) and extending towards the outlet of the crystalliser (11), the pressure of the cooling fluid in the lower zone (38) of the crystalliser (11) being a function of the desired value (g1) of an air interspace (36) between the sidewall (12) of the crystalliser (11) and the skin of the forming billet/bloom/slab (24), this desired value of air interspace (36) tending towards a zero value. Crystalliser for the continuous casting of billets/blooms /slabs (24), which is associated with a mould (10) and cooperates externally with a box-shaped structure creating a cooling chamber (14), in which a cooling fluid circulates, and cooperates internally with the skin of the billet/bloom/slab (24) being formed, the cooling chamber (14) containing an intermediate wall (20) creating a circulation channel (21) in cooperation with the outer surface of the sidewalls (12) of the crystalliser (11), there being included at least one upper zone (37) cooperating at least with the vicinity of, and with the part below, the meniscus (27) of liquid metal, a lower zone (38) being also included and beginning in the vicinity of the zone of separation of the forming skin from the inner surface of the sidewall (12) of the crystalliser (11) and extending towards the outlet of the crystalliser (11), the crystalliser (11) carrying out the method of the claims hereinebfore, at least one longitudinal zone of one sidewall (12) of the crystalliser (11) having a thickness between 4 and 15 mm. correlated functionally with the pressure of feed or with the range of pressures of feed of the cooling fluid within the relative circulation channel (21) in relation to the required inward displacement of that sidewall (12). <IMAGE>
Patent AU-557800-B2 (AU)
Title: Pyrido(2,3-d) pyridimin-5-ones
Inventor: LESHER GEORGE YOHE
IPC: C07D319/06
Filed: 1983-10-31
Granted: 1987-01-08
Abstract: 2-Q-6-Q min -8-R-pyrido[2,3-d]pyrimidin-5(8H)-ones (I), where Q is 4 (or 3)-hydroxyphenyl, 4(or 3)-methoxyphenyl, 4 (or 3)-pyridinyl or 4(or 3)-pyridinyl having one or two lower-alkyl substituents, R min  is hydrogen or alkyl having one to four carbon atoms, Q is hydrogen, amino or nitro, and R is alkyl having from one to four carbon atoms, CH(C2H5)2, (CH2)n = CHCH2 where n is 1 or 2, or Y-Z where Y is alkylene having from one to four carbon atoms and having its connecting linkages on different carbon atoms and Z is hydroxy, OR1 or NR1R2 where R1 and R2 are each methyl or ethyl, or acid-addition salts thereof and there preparation by reacting a 2-Q-4-R min -pyrido[2,3-d]pyrimidin-5(8H)-one of the Formula III (herein) where Q is 4 (or 3)-methoxyphenyl, 4(or 3)-pyridinyl or 4(or 3)-pyridinyl having one or two lower-alkyl substituents or alkali or alkaline earth metal salt thereof with an alkylating agent. Also shown is the cardiotonic use of I where Q is 4(or 3)-hydroxyphenyl, 4(or 3)-pyridinyl or 4(or 3)-pyridinyl having one or two lower-alkyl substituents and Q min  is hydrogen or amino. The novel compounds of Formula III and their preparation are also claimed.
Patent AU-718880-B2 (AU)
Title: Boxhorn array architecture using folded junctions
Inventor: PAUL JEFFREY A
IPC: H01Q13/02
Filed: 1999-01-13
Granted: 2000-04-20
Abstract: An inverted boxhorn antenna array comprising a power divider that is constructed from a single metal piece and a flat metal sheet that is fastened to a rear surface of the power divider. The power divider is fabricated using a variety of waveguide junctions coupled between substantially identical inverted boxhorn subarrays. The junctions includes a central magic tee junction for coupling energy from an input port into the power divider. Alternating folded shunt and folded series tee junctions are used to transfer power coupled by way of the central series junction to the inverted boxhorn subarrays. Specially dimensioned folded shunt and series tee junctions are used in the inverted boxhorn subarrays. Waveguide matched loads are bonded in waveguides between each of the inverted boxhorn radiators of the subarrays. A fully functional antenna assembly includes a radome cover, a quadrature correction plate 18a, and a twist polarizer disposed in front of radiating elements of the inverted boxhorn antenna array.
Patent AU-761875-B2 (AU)
Title: Communicating radio planning information among control nodes in a cellular communication network
Inventor: LINDGREN MAGNUS
IPC: H04W16/00
Filed: 1999-12-14
Granted: 2003-06-12
Abstract: In a cellular communication network, radio planning information is provided in a first control node that controls a plurality of first fixed-site radio transceivers which define a plurality of first cells in the cellular communication network. Without network operator support, the radio planning information is communicated from the first control node to a second control node that controls a plurality of second fixed-site radio transceivers which define in the cellular communication network a plurality of second cells including at least one second cell that is located adjacent to at least one of the first cells.
Patent AU-769266-B2 (AU)
Title: Differential impulse conveyor with linear motor drive
Inventor: SVEJKOVSKY PAUL A
IPC: B65G27/08
Filed: 1999-12-16
Granted: 2004-01-22
Abstract: A differential impulse conveyer for moving goods has a conveyer base (12) and a tray (16) for supporting the goods. The tray moves forward in a manner to carry the goods forward but moves backwards in a manner causing the goods to slip on the tray. This reciprocating motion is produced by an electrically powered motor (30). The tray is supported in a slidable manner on linear bearings (196,198) held between posts arising from the base.
Patent AU-612422-B2 (AU)
Title: 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives process for producing them and use thereof
Inventor: MOCHIDA EI
IPC: A61P9/12
Filed: 1988-10-31
Granted: 1991-07-11
Abstract: The present invention relates to novel 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime-O-sulfonic acid compounds, (I), processes for producing said compounds, intermediate compounds to produce said compounds and compositions containing said compounds with potent diuretic activity that can be used for treating and/or preventing hypertension, oedema and/or for removing ascites. <CHEM>   The present invention is based on the selection of 1-acyl-7-halo-2,3-dihydro-4(1H)-quinolinone-4-oxime-O-sulfonic acid compounds, namely heterocyclic-or fused heterocyclic- carbonyl derivatives at 1 position. The compounds of the present invention containing these substituents have potent hypotensive, anti-oedematous and diuretic effect as well as an activity to remove ascites and are extremely useful for the treatment of diseases and disorders mentioned above.
Patent AU-671598-B2 (AU)
Title: Hair spray compositions containing fluorosurfactant
Inventor: PEFFLY MARJORIE MOSSMAN
IPC: A61K8/70
Filed: 1992-08-18
Granted: 1996-09-05
Abstract: The present invention relates to hair spray compositions useful for spray application to the hair comprising from about 0.01 % to about 2 % of an ionic fluorosurfactant, from about 0.1 % to about 15 % of an ionic resin and a liquid vehicle, wherein the hair spray compositions are characterized by utilizing silicone macromer containing hair setting resins and/or by containing relatively high amounts of water, i.e., water and higher. This invention also relates to hair spray compositions useful for spray application to the hair comprising from about 0.01 % to about 2 % of an ionic fluorosurfactant, from about 0.1 % to about 15 % of an ionic silicone macromer-containing hair setting resin, and a liquid vehicle. This invention further relates to hair spray compositions comprising from about 0.01 % to about 2 % of an ionic fluorosurfactant, from about 0.1 % to about 15 % of an ionic silicone macromer-containing hair setting resin, and a liquid vehicle, wherein the hair setting resin has a weight average molecular weight of at least about 300,000.
Patent AU-771251-B2 (AU)
Title: Stable, nasally, orally or sublingually applicable pharmaceutical preparation
Inventor: SCHEIDL HELMUT
IPC: A61K38/095
Filed: 2001-01-10
Granted: 2004-03-18
Abstract: A stable, nasally, orally or sublingually applicable pharmaceutical preparation for administering to patients has an aqueous solution of desmopressin as the active agent. Said solution contains an osmoticum and a buffer which maintains the pH-value in the range of 4 to 6, preferably about 5. The buffer is malic acid, preferably in the form of a racemate. Thereby an improved stability of the desmopressin content in the preparation is obtained.
Patent AU-759522-B2 (AU)
Title: Method of controlling proliferation and differentiation of stem and progenitor cells
Inventor: PELED TONY
IPC: A61K35/12
Filed: 1999-02-08
Granted: 2003-04-17
Abstract: An expanded stem cell population expanded ex-vivo in a culture medium containing at least one copper chelator in an amount for permitting stem cells of said cell population to proliferate and, at the same time, for reducing a capacity of said stem cells to differentiate, said stem cells are hence expanded yet not further differentiated as compared to ex-vivo seeded stem cells from which said cell population developed.
Patent AU-777243-B2 (AU)
Title: Cushioned carpeted floor covering article comprising at least one integrated rubber protrusion
Inventor: KERR ROBERT C
IPC: B29C44/12
Filed: 2000-04-14
Granted: 2004-10-07
Abstract: This invention relates to a cushioned floor covering article wherein the mat includes a tufted carpet placed on the top side of a foam rubber sheet and at least one foam rubber protrusion integrated within at least a portion of the bottom side of the foam rubber sheet. Such an article provides effective removal of moisture, dirt, and debris from the footwear of pedestrians through the utilization of a carpet pile component. Furthermore, the utilization of a foam rubber backing also allows for either periodic heavy duty industrial-scale laundering in such standard washing machines or periodic washing and drying in standard in-home machines, both without appreciably damaging the inventive floor covering article, such as a floor mat. Additionally, the presence of integrated foam rubber protrusions within the mat structure provides an effective cushioning effect for pedestrian comfort as well as a means to prevent slippage of the article from its contacted surface. A method of producing such an inventive cushioned floor covering article is also provided.  <IMAGE>
Patent AU-608112-B2 (AU)
Title: Process of controlling the production of water vapor in a combustion plant
Inventor: KARBACH ALFRED
IPC: F22B31/00
Filed: 1989-01-13
Granted: 1991-03-21
Abstract: The production of water vapor is controlled in a plant for combusting fine-grained and dustlike solid fuels together with air in a combustion zone of a heat exchanger in the upper region of the combustion zone, a water vapor accumulator, which communicates with the heat exchanger, and a water vapor feed line leading from the water vapor accumulator to a turbine. The rate at which water vapor is produced is continually calculated and is compared with the desired value which is required by the turbine and the rates at which fuel and combustion air are supplied to the combustion zone are adjusted in accordance therewith. The combustion plant may comprise a fluidized bed cooler for cooling a part of the part of the combustion residue. That cooler may comprise a plurality of chambers provided with heat exchangers for an evaporation of feed water or for a super heating of water vapor. Any water vapor which is produced from feed water in said chambers will also be taken into account in the calculation of the total rate at which water vapor is produced in the combustion plant.
Patent AU-624117-B2 (AU)
Title: Pharmaceutical compositions having good stability
Inventor: JOSHI YATINDRA MOHAN
IPC: A61K31/19
Filed: 1989-02-23
Granted: 1992-06-04
Abstract: A pharmaceutical composition is provided which has excellent stability, when dispersed in water has a pH of at least about 9, and includes a medicament which is sensitive to a low pH environment such as pravastatin, one or more fillers such as lactose and/or microcrystalline cellulose, one or more binders, such as microcrystalline cellulose (dry binder) or polyvinylpyrrolidone (wet binder), one or more disintegrating agents such as croscarmellose sodium, one or more lubricants such as magnesium stearate and one or more basifying agents such as magnesium oxide.
Patent AU-773055-B2 (AU)
Title: Compositions and methods for the treatment of tumors
Inventor: BOTSTEIN DAVID
IPC: C12N15/11
Filed: 1999-12-02
Granted: 2004-05-13
Abstract: The invention concerns compositions and methods for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based upon the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product as compared to normal cells of the same tissue type and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain cancers, and may act as predictors of the prognosis of tumor treatment. The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Patent AU-748404-B2 (AU)
Title: Cyanoacetylureas for stabilizing halogenated polymers
Inventor: WEHNER WOLFGANG
IPC: C08K5/405
Filed: 1999-05-28
Granted: 2002-06-06
Abstract: Compositions containing a chlorine-containing polymer and at least one cyanoacetyl-urea derivative (I). Compositions containing a chlorine-containing polymer and at least one compound of formula (I): X = oxygen or sulfur; R = 2-22C acyloxyalkyl or 1-12C alkyl (optionally with 1-3 in-chain oxygen atoms and/or 1-3 hydroxyl substituents), 3-8C alkenyl, 5-8C cycloalkyl, 7-10C phenylalkyl or alkylphenyl, phenyl or naphthyl (all aromatic groups optionally substituted with OH, 1-12C alkyl or 1-4C alkoxy); R1 = H or a group as listed for R An Independent claim is also included for a method of stabilizing chlorine-containing polymers by incorporating (I).
Patent AU-667701-B2 (AU)
Title: Water-continuous emulsions based on polysaccharides
Inventor: CAMPBELL IAIN JAMES
IPC: A23L29/256
Filed: 1993-02-26
Granted: 1996-04-04
Abstract: The invention concerns water-continuous emulsions having a fat content of 1-60 wt.%, and wherein the aqueous phase consists of a gelling polysaccharide capable of forming a gel while the shear modulus of the aqueous phase must fulfil specific requirements and while the gelling polysaccharides are present as microgels with a mean equivalent diameter of less than 100  mu m. The emulsion is spoonable, meaning that it fulfils specific requirements as to yield value, Bingham viscosity and failure to stress. The emulsions can be used in non-dairy creams, in dressings and mayonnaises.
Patent AU-583257-B2 (AU)
Title: Contrast agents and method
Inventor: RUBIN DANIEL LEE
IPC: A61K49/04
Filed: 1984-12-28
Granted: 1989-04-27
Abstract: Contrast agents comprising aqueous emulsions or mixtures of iophendylate and their use in radiological examination of the small and large intestine after oral administration.
Patent AU-564681-B2 (AU)
Title: Polymeric deodorant/antiperspirant compositions
Inventor: COX IAN RUSSELL
IPC: C08F8/36
Filed: 1985-02-20
Granted: 1987-08-20
Abstract: Skin treatment products especially for absorbing axillary perspiration are described containing certain absorbent polymeric materials having good absorbency for aqueous solutions containing ionic species. The polymeric materials are made by a process which involves the polymerisation of a high internal phase emulsion containing 75% to 99% water as the internal phase.
Patent AU-567271-B2 (AU)
Title: Lyophilization of oil in water emulsion to give galenic form for oral administration
Inventor: LAFON LOUIS
IPC: A61K9/19
Filed: 1985-03-20
Granted: 1987-11-12
Abstract: This invention is concerned with a method for preparing a novel porous galenic form by lyophilization of an oil-in-water emulsion containing at least one pharmaceutically active ingredient, which comprises the following steps:a) preparation of the lipid phase by stirring at a temperature lower than or equal to 80°C so as to mix all the lipid-phase components, the lipid phase thus prepared being in the liquid state;b) preparation of the aqueous phase, which comprises at least one substance selected from the group consisting of organic fillers and thickening agents, by stirring at a temperature lower than or equal to 80°C so as to mix the water and the other components of the aqueous phase;c) preparation of an emulsion under stirring at a temperature within the range of 10°C to 80°C by introducing the liquid lipid phase into the aqueous phase so as to ensure that the resulting emulsion is homogeneous ;d) distribution of the resulting mixture into alveolar packs ;e) freezing of the contents of the alveolar packs at a temperature within the range of -20°C to -50°C followed by lyophilization of said contents under a pressure within the range of approximately 80 Pa to approximately 0.13 Pa with a heat supply such that the temperature of the treated mass is always lower than the initial melting temperature of said mass ;the pharmaceutically active substance being introduced prior to step d), if necessary by fractions.The invention also relates to the galenic form obtained in accordance with this method and constituting a novel industrial product.